Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sunita D. Srivastava, MD, FACS, is a vascular surgeon in the Department of Vascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. She is board-certified in general and vascular surgery, specializing in surgical and endovascular approaches to arterial and venous diseases, aortic aneurysm, carotid artery disease and renal artery occlusive disease.
Dr. Srivastava earned her medical degree from the State University of New York (SUNY) Health Science Center at Syracuse. She served her internship and residency in general surgery at SUNY Health Sciences Center, becoming Chief Resident in general surgery and earning the General Surgery Resident Teaching Award. She then received fellowships in vascular surgery and interventional radiology from the University of Rochester Medical Center in Rochester, NY followed by an endovascular fellowship at Malmo University Hospital in Malmo, Sweden.
Prior to her appointment to the Cleveland Clinic staff in 2000, Dr. Srivastava was an attending surgeon at the SUNY Health Science Center and St. Joseph’s Hospital and Health Center, Syracuse, NY. From 2003 to 2005 she was Assistant Professor of surgery and interventional radiology at the University of Michigan. She returned to Cleveland Clinic in 2005 as full staff in Vascular Surgery and Assistant Professor of Surgery in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Srivastava’s clinical research focuses on abdominal aortic and thoracic aortic endografting and the development of new devices and technology for endovascular surgery. She is site principal investigator on the REPLICA study of the genetics of carotid artery disease and the EMBOLDEN study, evaluating a new type of carotid stent for high risk patients.
She has been invited to present her research and clinical experiences at international and national medical conferences and symposia. She has authored or co-authored numerous book chapters and articles in medical textbooks and journals, including the Journal of Vascular Surgery, Cardiovascular Surgery and Annals of Vascular Surgery.
Dr. Srivastava is a Fellow of the American College of Surgeons. She is a member of the Peripheral Vascular Surgery Society, the Society for Cardiovascular Interventional Radiology, the Society for Vascular Surgery, the International Society of Endovascular Specialists, the Academy of Transcatheter Therapy and the American Medical Association. She also serves on several committees for the Society for Vascular Surgery and the Women’s Professional Staff Association at Cleveland Clinic.
Aortic aneurysms, carotid artery disease, cerebrovascular disease, peripheral artery disease, aorta surgery, carotid endarterectomy, carotid stenting, dialysis access procedures, stents for peripheral vascular disease, surgery for peripheral arterial disease (PAD), aortic aneurysm open repair and endovascular repair
Carotid Interventions Mini Fellowship, Lenox Hill Hospital
Innovations & Patents
Principal Site and Co-Investigator in multiple multicenter national research trials evaluating minimally invasive stents and technologies
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/26/2015, Dr. Srivastava has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.